The global interleukin 1 receptor associated kinase market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Interleukin-1 receptor-associated kinases refers to serine-threonine kinases that are involved in toll-like receptor and interleukin-1 signaling pathways, through which they regulate inflammation and innate immunity. The major factor accelerating the growth of the market is the increasing geriatrics population across the globe.

Moreover, the market is growing due to the prevalence of target diseases as well the growing demand for early detection of incurable diseases. However, the absence of a predefined regulatory framework may hinder the inflow of the demand for interleukin 1 receptor associated kinase, which in turn, will hamper the growth of the market. Some major players in the market include Amgen Inc., and Astellas Pharma Inc., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in October 2019, Taisho Pharmaceutical announced the initiation of an extension study of TS-152 in rheumatoid arthritis patients. The trial is expected to get completed by December 2022.

Market Coverage

    • The market number available for – 2020-2027

    • Base year- 2020

    • Forecast period- 2021-2027

    • Segment Covered- 

o By Type

o By Application

• Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

    • Competitive Landscape- Amgen Inc., and Astellas Pharma Inc., among others.

Key questions addressed by the report

    • What is the market growth rate?

    • Which segment and region dominate the market in the base year?

    • Which segment and region will project the fastest growth in the market?

    • How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

    • Who is the leader in the market?

    • How players are addressing challenges to sustain growth?

    • Where is the investment opportunity?

Global Interleukin 1 Receptor Associated Kinase Market Report by Segment

By Type

    • IRAK1

    • IRAK2

    • IRAK3

    • IRAK4

By Application

    • Gouty Arthritis

    • Psoriasis

    • Acute Myelocytic Leukemia

    • Others

Global Interleukin 1 Receptor Associated Kinase Market Report by Region

North America

    • United States

    • Canada

Europe

    • UK

    • Germany

    • Italy

    • Spain

    • France

    • Rest of Europe 

Asia-Pacific

    • China

    • India

    • Japan

    • South Korea

    • Rest of Asia-Pacific 

Rest of the World

    • Latin America 

    • Middle East & Africa